References
- Branford, M.M. (1976) “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding”, Anal. Biochem. 72, 248–254.
- Brown, M.S. and Goldstein, J.L. (1986) “A receptor-mediated pathway for cholesterol homeostasis”, Science 232, 34–47.
- Counsell, R.E. and Pohland, R.C. (1982) “Lipoproteins as potential site- specific delivery systems for diagnostic and therapeutic agents”, J. Med. Chem. 25, 1115–1120.
- Daugherty, A., Dunn, J.L., Rateri, D.L. and Heinecke, J.W. (1994) “Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions”, J. Clin. Investig. 94, 437–444.
- Hatch, F. and Lees, R.S. (1968) “Practical methods for plasma lipoprotein analysis”, Adv. Lipids Res. 6, 2–63.
- Lestavel-Delattre, S., Martin-Nizard, F., Clavey, V., Testard, P., Favre, G., Doualin, G., Houssaini, H.S., Bard, J.M., Duriez, P., Delbart, C., Soula, G., Lesieur, D., Lesieur, I., Cazin, J.C., Cazin, M. and Fruchart, J.C. (1992) “Low-density lipoprotein for delivery of an acrylo- phenone antineoplastic molecule into malignant cells”, Cancer Res. 52, 3629–3635.
- Mizushima, Y., Hamano, T. and Yokoyama, K. (1982) “Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion”, Ann. Rheum. Dis. 41, 263–267.
- Naito, M., Hayashi, T. and Iguchi, A. (1995) “New approaches to the prevention of atherosclerosis”, Drugs 50, 440–453.
- Pratten, M.K. and Lloyd, J.B. (1986) “Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro”, Biochim. Biophys. Acta 881, 307–313.
- Ross, R. (1993) “The pathogenesis of atherosclerosis: a perspective for the 1990s”, Nature 362, 801–809.
- Ryu, B.H., Mao, F.W., Lou, P., Gutman, R.L. and Greenspan, P. (1995) “Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein”, Biosci. Biotech. Biochem. 59, 1619–1622.
- Schuh, J., Fairclough, G.F. and Hashemeyer, R.H. (1978) “Oxygen- mediated heterogeneity of apo-low-density lipoprotein”, Proc. Natl Acad. Sci. USA 75, 3173–3177.
- Schneider, W.J. (1989) “The low density lipoprotein receptor”, Biochim. Biophys. Acta. 988, 303–317.
- Tauchi, Y., Takase, M., Zushida, I., Chono, S., Sato, J., Ito, K. and Morimoto, K. (1999) “Preparation of a complex of dexamethasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages”, J. Pharm. Sci. 88, 709–714.
- Tauchi, Y., Zushida, I., Yokota, M., Chono, S., Sato, J., Ito, K. and Morimoto, K. (2000) “Inhibitory effect of dexamethasone palmitate-low density lipoprotein complex on low density lipo- protein-induced macrophages foam cell formation”, Biol. Pharm. Bull. 23, 466–471.
- Tauchi, Y., Zushida, I., Chono, S., Sato, J., Ito, K. and Morimoto, K. (2001) “Effect of dexamethasone palmitate-low density lipoprotein complex on cholesterol ester accumulation in aorta of atherogenic model mice”, Biol. Pharm. Bull. 24, 925–929.
- Tokui, T., Kuroiwa, C., Marumatsu, S., Tokui, Y., Sasagawa, K., Ikeda, T. and Komai, T. (1995) “Plasma lipoproteins as targeting carriers to tumour tissues after administration of a lipophilic agent to mice”, Biopharm. Drug Dispos. 16, 91–103.
- Witztum, J.L. and Steinberg, D. (1991) “Role of oxidized low density lipoprotein in atherogenesis”, J. Clin. Investig. 88, 1785–1792.